HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 18.292 ↑ 0.07%
[as on 16 April, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 16 April, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 3.62% 0.07% 2.08% 4.62% 4.41% 14.44%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -6.21% 0.23% 2.96% 6.17% -3.29% -4.48% 13.16% 16.63% 14.4% 15.43%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -5.02% 0.08% 3.13% 6.12% -3.82% 5.92% 13.93% 12.41% 12.82% 13.08%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 1.86% 1.28% 2.53% 2.55% 1.83% 5.57% 25.51% 17.28% 20.91% 13.17%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -1.57% 0.94% 4.65% 7.45% 1.22% 5% 21.17% 21.42% 18.71% 16.53%
SBI PSU Fund - DIRECT PLAN - GROWTH 5.73% 0.4% 3.11% 4.85% 5.15% 19.87% 34.32% 29.23% 20.39% 16.68%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthJun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026
Returns 3.88% 5.33% -1.45% -1.45% 2.16% 1.22% -1.38% -4.65% 6.99% -4.36%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 8.02%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.70%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.87%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.67%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.05%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.83%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.49%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology4.12%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology3.80%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.71%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology3.63%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.61%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology3.50%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology2.89%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.88%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology2.86%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.46%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.33%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.88%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.78%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.72%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.68%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.58%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.50%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.29%
Pfizer Ltd.PFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.29%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology1.27%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.05%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies1.03%
Rubicon Research LimitedRUBICON (INE506V01022)Healthcare Services1.00%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services0.95%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.89%
Portfolio data is as on date 31 October, 2025

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
16 April, 202618.292 0.07%
15 April, 202618.279 1.83%
13 April, 202617.951 -0.49%
10 April, 202618.04 0.67%
9 April, 202617.92 0.96%
8 April, 202617.75 1.78%
7 April, 202617.439 0.4%
6 April, 202617.37 0.58%
2 April, 202617.269 -1.01%
1 April, 202617.446 -0.27%
31 March, 202617.494 -0.01%
30 March, 202617.495 -1.22%
27 March, 202617.711 -0.33%
25 March, 202617.77 1.94%
24 March, 202617.431 1.43%
23 March, 202617.186 -1.84%
20 March, 202617.508 1.16%
19 March, 202617.308 -2.29%
18 March, 202617.714 0.68%
17 March, 202617.595 0.63%
16 March, 202617.484 -0.64%
13 March, 202617.597 -2.52%
12 March, 202618.052 -0.52%
11 March, 202618.146 0.13%
10 March, 202618.122 1.28%
9 March, 202617.893 -0.88%
6 March, 202618.051 -0.06%
5 March, 202618.061 1.27%
4 March, 202617.835 -1.7%
2 March, 202618.144

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 18.292 as on 16 April, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 3.62% as on 16 April, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 14.44% as on 16 April, 2026.